Breast cancer survivors who took aspirin after
completing treatment were half as likely to die or have their tumors
spread around the body compared with survivors who didn't take aspirin,
a long-running study of 4,164 nurses showed.
The study is the first to find that regular
aspirin users had a lower risk of dying from breast cancer, according
to the study, published online today in the Journal of Clinical Oncology... read more
Find a Doctor/Researcher
Make an Appointment
Refer a Patient
Make a Gift
Penn Cancer Network
